ReviewCNS & neurological disorders drug targets2024

Curbing Rhes Actions: Mechanism-based Molecular Target for Huntington's Disease and Tauopathies.

Srinivasa Subramaniam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.